{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"chronic-inflammatory-demyelinating-polyradiculoneuropathy","columns":[{"gene":"","key":"population-8a0a6d0cc9831c7f2b52","label":"Chronic inflammatory demyelinating polyneuropathy","mondoId":"MONDO:0006702","onsetQualifier":null,"originColumnKey":"MONDO:0006702/ORPHA:2932","originalViews":[{"key":"MONDO:0006702/ORPHA:2932","label":"Chronic inflammatory demyelinating polyneuropathy","scopeLabel":"ORPHA:2932","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["00e7610fa29fb0bb87ee5697a0afed264fd727ae7cfea3e64e7610cf8cb3a76a","092d59c048c3b3f0dd0024ff6d986324c2f5700921579ecc3eed5fe78a35f05f","1e281abc50d1a0c1d722b4641ebac6e89b02050022906db423e9123d1f1637eb","2e045303f0160be620c94471b40f94198afc3c23d6c4977603da60e84db689fd","321345a365a51b8b8ae200e9d2da5e4f8f3932c59980fdc8cbabe19e4140cd73","34b0e222bece990af8afa9c246a566e4bfb1b0bc2faa80abbfbe8fcd8bcf747f","35795e19c6e6b911bb9cde8f37539e377226d80e2c47a49f1094b38c2324f6f4","3f4f61338ca30302f56040527a0c1b2488f2d4a43d0e95a395380088418f3e69","4716caf7f35acc25a900acb3ca9d4e3b711a4c7a5ddb6fac80b005f21358893d","4bceef640da191daaf693a9c7d5fa8c040eaedb096a9359ab4a0e567af320cd3","5357c9cb625dd2d82dfeefe2c036eccb106e8e6f55767c1518bb881dd23b7c6a","616c36cd5a3ce0845c69b88254e956da6a450ece29865496aaf8eb72d4a89248","82dcff5b3adc7bdac5511e8786d60f8b49e2469f1a0d8232b5f0bbf2d639c7e8","91d2333da3eebeef004c6e1ae134d3d5cd811dc4fabce55dc0f682e4206239cb","929530bd8e414b44b55df846ed6ee2266a2d901118c80278db0f1cc21438556d","a0035926d9ba738629d2ad183834809b71c09fc89c31b60bf5edaf95d5531b50","a439ed00714be24e6ab07ca533d6918f2a47f2c0972e1f6eaf65e6cac1169500","a6a4653cd3bae3c1d10237159da3d6ab0803053c9117709672428e57b8c31b7f","af6729a1de430681a6a3881a77d857721478574332b832f7ab61ee709127035d","c5e1f5c2e019af970dc3f323f6412bf78810f7cd29d944325ca533d87c90e1e7","ce5340711539d9ddbfe18d591586385ffeb975eaa2c88b92a6ea99628f421bce"],"recordQualifiers":{},"scopeLabel":"ORPHA:2932","sourceIds":["ORPHA:2932"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-8a0a6d0cc9831c7f2b52"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0040129","HP:0034137","HP:0034138","HP:0034136","HP:0034135","HP:0001284","HP:0000762"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":21,"sourceGroups":{"orphanet":21}},"features":[{"hpoId":"HP:0040129","label":"Abnormal nerve conduction velocity","primary":true},{"hpoId":"HP:0034137","label":"Anti-contactin-1 antibody positivity","primary":true},{"hpoId":"HP:0034138","label":"Anti-contactin-associated protein 1 antibody positivity","primary":true},{"hpoId":"HP:0034136","label":"Anti-neurofascin 186 antibody positivity","primary":true},{"hpoId":"HP:0034135","label":"Anti-neurofascin-155 antibody positivity","primary":true},{"hpoId":"HP:0001284","label":"Areflexia","primary":true},{"hpoId":"HP:0000762","label":"Decreased nerve conduction velocity","primary":true},{"hpoId":"HP:0003551","label":"Difficulty climbing stairs","primary":false},{"hpoId":"HP:0002527","label":"Falls","primary":false},{"hpoId":"HP:0030200","label":"Fatiguable weakness of proximal limb muscles","primary":false},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":false},{"hpoId":"HP:0030237","label":"Hand muscle weakness","primary":false},{"hpoId":"HP:0012078","label":"Motor conduction block","primary":false},{"hpoId":"HP:0003401","label":"Paresthesia","primary":false},{"hpoId":"HP:0011096","label":"Peripheral demyelination","primary":false},{"hpoId":"HP:0009830","label":"Peripheral neuropathy","primary":false},{"hpoId":"HP:0003481","label":"Segmental peripheral demyelination/remyelination","primary":false},{"hpoId":"HP:0010871","label":"Sensory ataxia","primary":false},{"hpoId":"HP:0003474","label":"Somatic sensory dysfunction","primary":false},{"hpoId":"HP:0010833","label":"Spontaneous pain sensation","primary":false},{"hpoId":"HP:0002317","label":"Unsteady gait","primary":false}],"ledeHtml":"Chronic inflammatory demyelinating polyneuropathy (CIDP) is a neurological disorder that causes progressive weakness and impaired sensory function in the legs and arms. Symptoms often include tingling or numbness (first in the toes and fingers), weakness of the arms and legs, loss of deep tendon reflexes, fatigue, and abnormal sensations. Other symptoms may include pain, difficulty swallowing (dysphagia), and double vision (diplopia). CIDP is thought to be caused by the immune system mistakenly attacking and damaging the myelin sheath (protective cover of nerve fibers) of the peripheral nerves. CIDP is closely related to Guillain-Barre syndrome (GBS) and is considered the &quot;chronic counterpart&quot; of GBS.","mondoId":"MONDO:0006702","node":{"canonicalSlug":"chronic-inflammatory-demyelinating-polyradiculoneuropathy","comparisons":[{"documentSha256":"2acd32e70b327286984950759de66096e7d69df1a2a726ff8ff58b4bfc5ff235","key":"legacy-chronic-inflammatory-demyelinating-polyradiculoneuropathy","kind":"legacy","label":"chronic inflammatory demyelinating polyradiculoneuropathy","memberIds":["MONDO:0006702"],"mondoId":"MONDO:0006702","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/chronic-inflammatory-demyelinating-polyradiculoneuropathy.2acd32e70b327286984950759de66096e7d69df1a2a726ff8ff58b4bfc5ff235.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Chronic inflammatory demyelinating polyradiculoneuropathy","originalSourceId":"ORPHA:2932","paragraphs":["Chronic inflammatory demyelinating polyneuropathy (CIDP) is a neurological disorder that causes progressive weakness and impaired sensory function in the legs and arms. Symptoms often include tingling or numbness (first in the toes and fingers), weakness of the arms and legs, loss of deep tendon reflexes, fatigue, and abnormal sensations. Other symptoms may include pain, difficulty swallowing (dysphagia), and double vision (diplopia). CIDP is thought to be caused by the immune system mistakenly attacking and damaging the myelin sheath (protective cover of nerve fibers) of the peripheral nerves. CIDP is closely related to Guillain-Barre syndrome (GBS) and is considered the \"chronic counterpart\" of GBS."],"rawAttribution":"MONDO:0006702","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T15:51:20Z","upstream":"GARD:0006102","url":"https://rarediseases.info.nih.gov/diseases/6102"},"ownColumnKeys":["population-8a0a6d0cc9831c7f2b52"],"publication":"published","relationships":[{"kind":"parent","label":"demyelinating polyneuropathy","mondoId":"MONDO:0003334","slug":null},{"kind":"parent","label":"chronic polyneuropathy","mondoId":"MONDO:0003335","slug":null},{"kind":"parent","label":"polyradiculoneuropathy","mondoId":"MONDO:0006915","slug":"polyradiculoneuropathy"},{"kind":"parent","label":"inflammatory disease","mondoId":"MONDO:0021166","slug":null},{"kind":"child","label":"Lewis-Sumner syndrome","mondoId":"MONDO:0018826","slug":"lewis-sumner"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"00e7610fa29fb0bb87ee5697a0afed264fd727ae7cfea3e64e7610cf8cb3a76a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0030237","is_excluded":false,"label":"Hand muscle weakness","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"092d59c048c3b3f0dd0024ff6d986324c2f5700921579ecc3eed5fe78a35f05f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002317","is_excluded":false,"label":"Unsteady gait","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1e281abc50d1a0c1d722b4641ebac6e89b02050022906db423e9123d1f1637eb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003481","is_excluded":false,"label":"Segmental peripheral demyelination/remyelination","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2e045303f0160be620c94471b40f94198afc3c23d6c4977603da60e84db689fd","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034137","is_excluded":false,"label":"Anti-contactin-1 antibody positivity","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"321345a365a51b8b8ae200e9d2da5e4f8f3932c59980fdc8cbabe19e4140cd73","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0009830","is_excluded":false,"label":"Peripheral neuropathy","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"34b0e222bece990af8afa9c246a566e4bfb1b0bc2faa80abbfbe8fcd8bcf747f","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034138","is_excluded":false,"label":"Anti-contactin-associated protein 1 antibody positivity","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"35795e19c6e6b911bb9cde8f37539e377226d80e2c47a49f1094b38c2324f6f4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0040129","is_excluded":false,"label":"Abnormal nerve conduction velocity","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3f4f61338ca30302f56040527a0c1b2488f2d4a43d0e95a395380088418f3e69","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034135","is_excluded":false,"label":"Anti-neurofascin-155 antibody positivity","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4716caf7f35acc25a900acb3ca9d4e3b711a4c7a5ddb6fac80b005f21358893d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000762","is_excluded":false,"label":"Decreased nerve conduction velocity","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4bceef640da191daaf693a9c7d5fa8c040eaedb096a9359ab4a0e567af320cd3","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030200","is_excluded":false,"label":"Fatiguable weakness of proximal limb muscles","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5357c9cb625dd2d82dfeefe2c036eccb106e8e6f55767c1518bb881dd23b7c6a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001284","is_excluded":false,"label":"Areflexia","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"616c36cd5a3ce0845c69b88254e956da6a450ece29865496aaf8eb72d4a89248","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011096","is_excluded":false,"label":"Peripheral demyelination","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"82dcff5b3adc7bdac5511e8786d60f8b49e2469f1a0d8232b5f0bbf2d639c7e8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003551","is_excluded":false,"label":"Difficulty climbing stairs","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"91d2333da3eebeef004c6e1ae134d3d5cd811dc4fabce55dc0f682e4206239cb","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034136","is_excluded":false,"label":"Anti-neurofascin 186 antibody positivity","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"929530bd8e414b44b55df846ed6ee2266a2d901118c80278db0f1cc21438556d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010833","is_excluded":false,"label":"Spontaneous pain sensation","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a0035926d9ba738629d2ad183834809b71c09fc89c31b60bf5edaf95d5531b50","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a439ed00714be24e6ab07ca533d6918f2a47f2c0972e1f6eaf65e6cac1169500","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003401","is_excluded":false,"label":"Paresthesia","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a6a4653cd3bae3c1d10237159da3d6ab0803053c9117709672428e57b8c31b7f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012078","is_excluded":false,"label":"Motor conduction block","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"af6729a1de430681a6a3881a77d857721478574332b832f7ab61ee709127035d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003474","is_excluded":false,"label":"Somatic sensory dysfunction","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c5e1f5c2e019af970dc3f323f6412bf78810f7cd29d944325ca533d87c90e1e7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002527","is_excluded":false,"label":"Falls","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ce5340711539d9ddbfe18d591586385ffeb975eaa2c88b92a6ea99628f421bce","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2932","disease_name":"Chronic inflammatory demyelinating polyneuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0010871","is_excluded":false,"label":"Sensory ataxia","onset_id":null,"reference":"ORPHA:2932","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/6102\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0006702\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0006102</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Chronic inflammatory demyelinating polyneuropathy (CIDP) is a neurological disorder that causes progressive weakness and impaired sensory function in the legs and arms. Symptoms often include tingling or numbness (first in the toes and fingers), weakness of the arms and legs, loss of deep tendon reflexes, fatigue, and abnormal sensations. Other symptoms may include pain, difficulty swallowing (dysphagia), and double vision (diplopia). CIDP is thought to be caused by the immune system mistakenly attacking and damaging the myelin sheath (protective cover of nerve fibers) of the peripheral nerves. CIDP is closely related to Guillain-Barre syndrome (GBS) and is considered the &quot;chronic counterpart&quot; of GBS.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/6102\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"chronic-inflammatory-demyelinating-polyradiculoneuropathy","sourceDocuments":[{"name":"GARD: Chronic inflammatory demyelinating polyradiculoneuropathy","reviewed":null,"source_release":"2026-10-21T15:51:20Z","url":"https://rarediseases.info.nih.gov/diseases/6102"},{"name":"MONDO: chronic inflammatory demyelinating polyradiculoneuropathy","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0006702"}],"sourceNote":"","synonyms":["chronic inflammatory demyelinating polyneuropathy","chronic inflammatory demyelinating polyradiculoneuropathy","chronic relapsing polyneuropathy","CIDP"],"takeawayHtml":"","title":"chronic inflammatory demyelinating polyradiculoneuropathy"},"schemaVersion":1}
